Lightspeed Microscopy accelerates drug development and improves clinical diagnostics by transforming the field of pathology from 2D and slide-based to 3D and digital. Lightspeed has a full stack solution with proprietary sample preparation, patented open-top light-sheet microscopy, cloud-based data processing, visualization, and AI analysis. Multiple Pharma companies are using Lightspeed's 3D pathology product to accelerate their preclinical drug development through better understanding of fibrosis structure and collagen characterization.

Team Members

Nicholas Reder

Dr. Nicholas Reder

Chief Executive Officer


Elizabeth Madonick

Sales Lead

headshot - jpg

Alex Springer

Chief of Staff